Skip to main content
. 2018 Nov 16;8(1):10.1128/ecosalplus.ESP-0002-2018. doi: 10.1128/ecosalplus.esp-0002-2018

Figure 4.

Figure 4

Semisynthetic aminoglycosides. (A) Kanamycin B scaffold with modification to dibekacin and subsequent modification to arbekacin. (B) Kanamycin A scaffold with modification to amikacin. (C) Gentamicin B scaffold with modification to isepamicin. (D) Sisomicin scaffold with modification to netilmicin and with modification to plazomicin. Green highlights indicate new chemical modifications; green circles indicate removal of hydroxyl groups.